Drawing investor attention can pose a challenge, even for companies with groundbreaking, new science. In a space teeming with competition, it’s vital that emerging biophama companies developing innovative therapies also establish strong messaging to reach and intrigue potential investors.
Posts by Stephanie Carrington
Stephanie Carrington is a Managing Director on Westwicke's life sciences team. She has extensive experience in healthcare investor relations and strategic communications. She has a BA in economics and international relations from Smith College and an MBA in finance and international business from New York University’s Stern School of Business.
ICR ACQUIRES WESTWICKE PARTNERS
The entire Westwicke team will combine with ICR’s existing healthcare investor and public relations practice, forming a new entity: Westwicke, An ICR Company.